In a recent win for health care providers, the United States Court of Appeals for the Fifth Circuit has affirmed a lower court’s decision to vacate key portions of regulations issued by the U.S. Departments of Treasury, Labor, and Health and Human Services (collectively, the “Departments”) under the No Surprises Act (“NSA”).  The decision marks the most recent chapter in the ongoing legal challenges involving the NSA.

Prior Rulemaking, Lower Court Litigation, and Issues on Appeal

The NSA was enacted in 2020 to protect patients from unexpected medical bills incurred from out‑of‑network care, particularly during emergencies or when receiving non‑emergency services at in‑network facilities.  These “surprise” bills often occur when patients unknowingly receive treatment from providers outside their insurance network leading to unexpected out‑of‑pocket costs.  To address this, the NSA limits patient expenses to the amounts they would have paid had the services been rendered on an in‑network basis.  The NSA also establishes a process for health care providers and payers to determine the appropriate reimbursement rate for the services.  Specifically, the NSA sets forth an open negotiation period followed by a “winner‑take‑all” or “baseball‑style” arbitration, in which an independent dispute resolution entity (“IDRE”) selects an offer from either the payer or provider as the payment amount.

In selecting offers, the NSA directs IDREs to consider multiple factors, including the Qualifying Payment Amount (“QPA”), which is the median in‑network rate paid by insurers for specific services in a geographic area, as well as the provider’s experience, patient acuity, the complexity of the services provided, the market share held by the provider or insurer in the geographic region, and the history of negotiations between the provider and insurer.  Crucially, the NSA does not place greater weight on any of the factors.  The initial regulations promulgated by the Departments, however, directed IDREs to consider the QPA first, thereby creating a presumption that the QPA was the appropriate jumping‑off point in determining the out‑of‑network rate.

In response, health care providers in Texas represented by the Texas Medical Association (“TMA”) filed suit, arguing that these regulations unfairly tilted the arbitration in favor of insurers by prioritizing the QPA.  As alleged by the TMA, this overemphasis of the QPA neglected the multifaceted approach mandated by the NSA, potentially compromising the fairness of the arbitration process.  The United States District Court for the Eastern District of Texas agreed, ultimately ruling that the Departments’ regulations improperly elevated the QPA above the other factors, and therefore vacated those provisions of the regulations.  The Departments appealed.

On appeal, the Fifth Circuit upheld the District Court’s order, holding that the challenged regulations imposed extra‑statutory requirements that skewed the arbitration process in favor of insurers.  The Fifth Circuit identified three specific impositions that exceeded the Departments’ authority under the NSA and the Administrative Procedures Act.  First, the Fifth Circuit observed that the Departments’ regulations mandated that arbitrators prioritize the QPA before considering other factors, which effectively contravened the NSA’s mandate for an equitable consideration of all factors.  By structurally embedding the QPA as the initial consideration, the Fifth Circuit reasoned, the Departments’ regulations distorted the intended parity among the factors, thereby inherently benefiting insurers.  In the Fifth Circuit’s view, such a configuration not only skewed the balance of the arbitration process in favor of payers, but also undermined the broader legislative goal of providing disputing parties with a balanced and impartial dispute resolution mechanism.

Second, the Fifth Circuit held that the regulations unduly restricted IDREs from considering any information not deemed “credible” or directly related to the QPA, thereby limiting the scope of evidence that could influence arbitration decisions.  This restriction, the Fifth Circuit held, effectively and improperly narrowed the IDREs’ ability to make fully informed decisions based on a comprehensive range of evidence, all of which was crucial to achieving the fair adjudication objectives set forth in the NSA.  Thus, this limitation not only compromised the ability of IDREs to weigh all pertinent information, but also undermined the NSA’s intention to facilitate a holistic and unbiased decision‑making process once arbitration had commenced.

Finally, the Fifth Circuit declared that the Departments’ requirement that IDREs provide written explanations whenever their decisions deviated from the QPA conflicted with the NSA.  Here, the Fifth Circuit held that this added procedural burden could discourage IDREs from considering and incorporating other relevant, non‑QPA, factors, all of which could be critical for a balanced and equitable outcome.  By imposing such a requirement, the Fifth Circuit held that the Departments not only created a disincentive for IDREs to depart from the QPA, but once again skewed the arbitration process in favor of insurers, who benefit from the QPA’s typically lower rates.

Collectively, the Fifth Circuit found that each of these procedural hurdles compromised the integrity and fairness of the arbitration process, contravening the equitable principles envisioned by the NSA.

What’s Next?  Additional Rulemaking and/or Litigation in a Post‑Chevron World

Although a win for health care providers, the Fifth Circuit’s decision is not the final word in the implementation of the NSA.  Indeed, lingering questions remain as to whether the Departments will issue new regulations that adhere more closely to the NSA or else appeal the Fifth Circuit’s ruling.  Either option carries risks.  If the Departments issue new regulations, they may face additional challenges from health care providers.  If they appeal, their next stop would be the Supreme Court, which has already curtailed agency authority.  Either way, the regulatory framework surrounding the NSA remains in flux as additional rulemaking issued by the Departments earlier this year is expected to become final later this calendar year.  Accordingly, health care providers should continue timely filing negotiation and arbitration notices under the NSA and retain skilled counsel to advise them on compliance with the NSA.

Proskauer’s Health Care Group is closely monitoring developments related to the NSA and its implementation.  We are committed to providing timely updates and guidance to help our clients understand and adapt to these changes.  Subscribe to our Health Care Law Brief to stay informed about the latest developments in healthcare law and policy.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of D. Austin Rettew D. Austin Rettew

Austin Rettew is an associate in the Corporate and Litigation Departments and a member of the Health Care Group at Proskauer.  His practice focuses on regulatory litigation and compliance within the health care sector.  He provides strategic counsel to health care providers on…

Austin Rettew is an associate in the Corporate and Litigation Departments and a member of the Health Care Group at Proskauer.  His practice focuses on regulatory litigation and compliance within the health care sector.  He provides strategic counsel to health care providers on managed care and commercial payer disputes, offering comprehensive regulatory, compliance, and reimbursement guidance to a diverse client base, including hospital systems, dialysis providers, anesthesia associations, physician practices, post-acute care service providers, and healthcare technology and revenue cycle management companies.

Austin is experienced in regulatory litigation and routinely advises clients operating within the complex landscape of the heavily regulated health care industry.  His work in this area addresses compliance issues related to ERISA, the Affordable Care Act, the Medicare Secondary Payer Act, the Medicare Advantage program, the federal No Surprises Act, state surprise billing laws, state insurance laws, and the Mental Health Parity and Addiction Equity Act.  He has represented providers, pharmaceutical manufacturers, and other health care companies in government investigations involving the Anti-Kickback Statute, the False Claims Act, and qui tam “whistleblower” lawsuits, working closely with company executives and consultants to develop effective compliance regimes while minimizing business disruption.

Austin also advises investors, owners, operators, and developers of long-term care and senior housing communities on health care transactions, regulatory compliance, corporate due diligence, and change of ownership procedures for state licensure, certificate of need, and Medicare and Medicaid certifications.  He also drafts industry-specific comment letters for proposed regulations, ensuring that client perspectives and concerns are clearly communicated to regulatory bodies.

While in law school, Austin was an articles editor of the George Washington University Law School’s Public Contract Law Journal.  Austin also served as a judicial intern for Judge Elizabeth S. Stong of the U.S. Bankruptcy Court for the Eastern District of New York and Magistrate Judge Lois Bloom of the U.S. District Court for the Eastern District of New York.

Prior to joining Proskauer, Austin was an associate in the Complex Litigation group at ArentFox Schiff.

Photo of Vinay Kohli Vinay Kohli

Vinay Kohli is a partner in the Health Care Group and Litigation Department.  Vinay is a seasoned trial lawyer with more than a decade of experience representing clients in the health care provider industry—including hospital systems, physicians, and post-acute care facilities as well…

Vinay Kohli is a partner in the Health Care Group and Litigation Department.  Vinay is a seasoned trial lawyer with more than a decade of experience representing clients in the health care provider industry—including hospital systems, physicians, and post-acute care facilities as well as healthcare technology and revenue cycle management companies.

Recognized for his focus and commitment to the healthcare industry, a wide range of health care businesses use Vinay as an outside general counsel to guide them on strategic planning issues, compliance matters, operational questions, and reimbursement issues.  He provides regulatory, compliance, reimbursement advice on topics that range from venture formation and risk management to an array of contract negotiations.

He is also experienced in defending health care fraud and abuse litigation, prosecuting managed care disputes against payors, and handling government investigations.  He is frequently called upon to serve as lead trial counsel in commercial litigation disputes for health care industry clients that span the gamut from trade secret misappropriation, unfair business practices, and breach of fiduciary claims.

Vinay received his B.B.A., magna cum laude, M.A., and J.D. from the University of Texas at Austin in 2005, 2006, and 2009 respectively.

Prior to joining Proskauer, Vinay was a partner in the Healthcare and Commercial Litigation groups at King & Spalding.